Introduction: FOXO4-DRI peptide allows selective apoptosis of senescent cells, supports metabolic reports, and ensures steadiness in exploration, improving reproducibility and advancing aging and oncology investigations. every day laboratory workflows often expose gaps in which present compounds fall short to address mobile senescence comprehensiv